Pamela Stephenson - Sep 27, 2021 Form 4 Insider Report for ALBIREO PHARMA, INC. (ALBO)

Role
Chief Commercial Officer
Signature
/s/ Jason Duncan, Attorney-in-fact
Stock symbol
ALBO
Transactions as of
Sep 27, 2021
Transactions value $
-$14,456
Form type
4
Date filed
9/28/2021, 04:32 PM
Previous filing
Aug 5, 2021
Next filing
Dec 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale -$14.5K -451 -1.7% $32.05 26.1K Sep 27, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 11,188 shares of common stock and 14,875 restricted stock units.